Probingon AB

Probingon develops clinical wearables and IoMT sensor solutions that communicate via a fat-tissue transmission layer, enabling body area networks that link implants and surface sensors for closed-loop neuromodulation therapy. Their primary beneficiaries are physicians, therapists, and patients, particularly in rehabilitation and chronic disease management, where continuous, non-invasive monitoring and adaptive stimulation can improve treatment outcomes and quality of life.